IRONWOOD PHARMACEUTICALS INC·4

Sep 19, 5:05 PM ET

Moukheibir Catherine 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Sep 19, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Transactions
  • Award

    Class A Common Stock

    2023-09-15+2,098127,061 total
Footnotes (1)
  • [F1]Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION